TRPM7 and neoplasm: Furthermore, TRPM7 has a 13-fold higher expression in pancreatic ductal adenocarcinoma (PDAC) compared with non-cancer tissue, with TRPM7 expression correlated with tumour progression and a poor survival rate [142].